HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan · Delayed Price · Currency is TWD 57.50
0.00 (0.00%)
Oct 23, 2025, 2:27 PM CST
HeXun Biosciences Market Cap
HeXun Biosciences has a market cap or net worth of 2.65 billion as of October 24, 2025. Its market cap has decreased by -22.92% in one year.
Market Cap
2.65B
Enterprise Value
2.25B
Revenue
304.45M
Ranking
n/a
PE Ratio
20.17
Stock Price
57.50
Market Cap Chart
Since September 7, 2023, HeXun Biosciences's market cap has decreased from 4.16B to 2.65B, a decrease of -36.39%. That is a compound annual growth rate of -19.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 2.65B | -14.81% |
| Dec 31, 2024 | 3.11B | 4.17% |
| Dec 29, 2023 | 2.98B | -28.32% |
| Sep 7, 2023 | 4.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 255.14B |
| PharmaEssentia | 191.57B |
| Bora Pharmaceuticals Co., LTD. | 80.18B |
| Lotus Pharmaceutical | 76.53B |
| Lumosa Therapeutics | 52.22B |
| Oneness Biotech | 30.13B |
| Polaris Group | 27.66B |
| Center Laboratories | 25.79B |